Report ID: GIR2211030027 | Category: Service & Software | Pages: 100 | Format: PDF | Published Date: December 05,2022
1 Market Overview 1.1 Product Overview and Scope of Pediatric Oncology Treatment 1.2 Market Estimation Caveats and Base Year 1.3 Classification of Pediatric Oncology Treatment by Therapy 1.3.1 Overview: Global Pediatric Oncology Treatment Market Size by Therapy: 2017 Versus 2021 Versus 2028 1.3.2 Global Pediatric Oncology Treatment Consumption Value Market Share by Therapy in 2021 1.3.3 Radiotherapy 1.3.4 Chemotherapy 1.4 Global Pediatric Oncology Treatment Market by Application 1.4.1 Overview: Global Pediatric Oncology Treatment Market Size by Application: 2017 Versus 2021 Versus 2028 1.4.2 Leukemia 1.4.3 Neuroblastoma 1.4.4 Brain Cancer 1.4.5 Retinoblastoma 1.4.6 Lymphoma 1.4.7 Others 1.5 Global Pediatric Oncology Treatment Market Size & Forecast 1.6 Global Pediatric Oncology Treatment Market Size and Forecast by Region 1.6.1 Global Pediatric Oncology Treatment Market Size by Region: 2017 VS 2021 VS 2028 1.6.2 Global Pediatric Oncology Treatment Market Size by Region, (2017-2028) 1.6.3 North America Pediatric Oncology Treatment Market Size and Prospect (2017-2028) 1.6.4 Europe Pediatric Oncology Treatment Market Size and Prospect (2017-2028) 1.6.5 Asia-Pacific Pediatric Oncology Treatment Market Size and Prospect (2017-2028) 1.6.6 South America Pediatric Oncology Treatment Market Size and Prospect (2017-2028) 1.6.7 Middle East and Africa Pediatric Oncology Treatment Market Size and Prospect (2017-2028) 2 Company Profiles 2.1 United Therapeutics Corporation 2.1.1 United Therapeutics Corporation Details 2.1.2 United Therapeutics Corporation Major Business 2.1.3 United Therapeutics Corporation Pediatric Oncology Treatment Product and Solutions 2.1.4 United Therapeutics Corporation Pediatric Oncology Treatment Revenue, Gross Margin and Market Share (2017-2022) 2.1.5 United Therapeutics Corporation Recent Developments and Future Plans 2.2 Apeiron Biologics 2.2.1 Apeiron Biologics Details 2.2.2 Apeiron Biologics Major Business 2.2.3 Apeiron Biologics Pediatric Oncology Treatment Product and Solutions 2.2.4 Apeiron Biologics Pediatric Oncology Treatment Revenue, Gross Margin and Market Share (2017-2022) 2.2.5 Apeiron Biologics Recent Developments and Future Plans 2.3 Baxter 2.3.1 Baxter Details 2.3.2 Baxter Major Business 2.3.3 Baxter Pediatric Oncology Treatment Product and Solutions 2.3.4 Baxter Pediatric Oncology Treatment Revenue, Gross Margin and Market Share (2017-2022) 2.3.5 Baxter Recent Developments and Future Plans 2.4 Cellectar Biosciences 2.4.1 Cellectar Biosciences Details 2.4.2 Cellectar Biosciences Major Business 2.4.3 Cellectar Biosciences Pediatric Oncology Treatment Product and Solutions 2.4.4 Cellectar Biosciences Pediatric Oncology Treatment Revenue, Gross Margin and Market Share (2017-2022) 2.4.5 Cellectar Biosciences Recent Developments and Future Plans 2.5 Pfizer 2.5.1 Pfizer Details 2.5.2 Pfizer Major Business 2.5.3 Pfizer Pediatric Oncology Treatment Product and Solutions 2.5.4 Pfizer Pediatric Oncology Treatment Revenue, Gross Margin and Market Share (2017-2022) 2.5.5 Pfizer Recent Developments and Future Plans 2.6 Bayer 2.6.1 Bayer Details 2.6.2 Bayer Major Business 2.6.3 Bayer Pediatric Oncology Treatment Product and Solutions 2.6.4 Bayer Pediatric Oncology Treatment Revenue, Gross Margin and Market Share (2017-2022) 2.6.5 Bayer Recent Developments and Future Plans 2.7 Macrogenics 2.7.1 Macrogenics Details 2.7.2 Macrogenics Major Business 2.7.3 Macrogenics Pediatric Oncology Treatment Product and Solutions 2.7.4 Macrogenics Pediatric Oncology Treatment Revenue, Gross Margin and Market Share (2017-2022) 2.7.5 Macrogenics Recent Developments and Future Plans 2.8 Sartorius 2.8.1 Sartorius Details 2.8.2 Sartorius Major Business 2.8.3 Sartorius Pediatric Oncology Treatment Product and Solutions 2.8.4 Sartorius Pediatric Oncology Treatment Revenue, Gross Margin and Market Share (2017-2022) 2.8.5 Sartorius Recent Developments and Future Plans 2.9 Merck 2.9.1 Merck Details 2.9.2 Merck Major Business 2.9.3 Merck Pediatric Oncology Treatment Product and Solutions 2.9.4 Merck Pediatric Oncology Treatment Revenue, Gross Margin and Market Share (2017-2022) 2.9.5 Merck Recent Developments and Future Plans 2.10 BioNTech 2.10.1 BioNTech Details 2.10.2 BioNTech Major Business 2.10.3 BioNTech Pediatric Oncology Treatment Product and Solutions 2.10.4 BioNTech Pediatric Oncology Treatment Revenue, Gross Margin and Market Share (2017-2022) 2.10.5 BioNTech Recent Developments and Future Plans 2.11 Dr.Reddy's Laboratories 2.11.1 Dr.Reddy's Laboratories Details 2.11.2 Dr.Reddy's Laboratories Major Business 2.11.3 Dr.Reddy's Laboratories Pediatric Oncology Treatment Product and Solutions 2.11.4 Dr.Reddy's Laboratories Pediatric Oncology Treatment Revenue, Gross Margin and Market Share (2017-2022) 2.11.5 Dr.Reddy's Laboratories Recent Developments and Future Plans 3 Market Competition, by Players 3.1 Global Pediatric Oncology Treatment Revenue and Share by Players (2017-2022) 3.2 Market Share Analysis (2021) 3.2.1 Market Share of Pediatric Oncology Treatment by Company Revenue 3.2.2 Top 3 Pediatric Oncology Treatment Players Market Share in 2021 3.2.3 Top 6 Pediatric Oncology Treatment Players Market Share in 2021 3.3 Pediatric Oncology Treatment Market: Overall Company Footprint Analysis 3.3.1 Pediatric Oncology Treatment Market: Region Footprint 3.3.2 Pediatric Oncology Treatment Market: Company Product Type Footprint 3.3.3 Pediatric Oncology Treatment Market: Company Product Application Footprint 3.4 New Market Entrants and Barriers to Market Entry 3.5 Mergers, Acquisition, Agreements, and Collaborations 4 Market Size Segment by Therapy 4.1 Global Pediatric Oncology Treatment Consumption Value and Market Share by Therapy (2017-2022) 4.2 Global Pediatric Oncology Treatment Market Forecast by Therapy (2023-2028) 5 Market Size Segment by Application 5.1 Global Pediatric Oncology Treatment Consumption Value Market Share by Application (2017-2022) 5.2 Global Pediatric Oncology Treatment Market Forecast by Application (2023-2028) 6 North America 6.1 North America Pediatric Oncology Treatment Consumption Value by Therapy (2017-2028) 6.2 North America Pediatric Oncology Treatment Consumption Value by Application (2017-2028) 6.3 North America Pediatric Oncology Treatment Market Size by Country 6.3.1 North America Pediatric Oncology Treatment Consumption Value by Country (2017-2028) 6.3.2 United States Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 6.3.3 Canada Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 6.3.4 Mexico Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 7 Europe 7.1 Europe Pediatric Oncology Treatment Consumption Value by Therapy (2017-2028) 7.2 Europe Pediatric Oncology Treatment Consumption Value by Application (2017-2028) 7.3 Europe Pediatric Oncology Treatment Market Size by Country 7.3.1 Europe Pediatric Oncology Treatment Consumption Value by Country (2017-2028) 7.3.2 Germany Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 7.3.3 France Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 7.3.4 United Kingdom Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 7.3.5 Russia Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 7.3.6 Italy Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 8 Asia-Pacific 8.1 Asia-Pacific Pediatric Oncology Treatment Consumption Value by Therapy (2017-2028) 8.2 Asia-Pacific Pediatric Oncology Treatment Consumption Value by Application (2017-2028) 8.3 Asia-Pacific Pediatric Oncology Treatment Market Size by Region 8.3.1 Asia-Pacific Pediatric Oncology Treatment Consumption Value by Region (2017-2028) 8.3.2 China Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 8.3.3 Japan Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 8.3.4 South Korea Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 8.3.5 India Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 8.3.6 Southeast Asia Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 8.3.7 Australia Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 9 South America 9.1 South America Pediatric Oncology Treatment Consumption Value by Therapy (2017-2028) 9.2 South America Pediatric Oncology Treatment Consumption Value by Application (2017-2028) 9.3 South America Pediatric Oncology Treatment Market Size by Country 9.3.1 South America Pediatric Oncology Treatment Consumption Value by Country (2017-2028) 9.3.2 Brazil Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 9.3.3 Argentina Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 10 Middle East & Africa 10.1 Middle East & Africa Pediatric Oncology Treatment Consumption Value by Therapy (2017-2028) 10.2 Middle East & Africa Pediatric Oncology Treatment Consumption Value by Application (2017-2028) 10.3 Middle East & Africa Pediatric Oncology Treatment Market Size by Country 10.3.1 Middle East & Africa Pediatric Oncology Treatment Consumption Value by Country (2017-2028) 10.3.2 Turkey Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 10.3.3 Saudi Arabia Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 10.3.4 UAE Pediatric Oncology Treatment Market Size and Forecast (2017-2028) 11 Market Dynamics 11.1 Pediatric Oncology Treatment Market Drivers 11.2 Pediatric Oncology Treatment Market Restraints 11.3 Pediatric Oncology Treatment Trends Analysis 11.4 Porters Five Forces Analysis 11.4.1 Threat of New Entrants 11.4.2 Bargaining Power of Suppliers 11.4.3 Bargaining Power of Buyers 11.4.4 Threat of Substitutes 11.4.5 Competitive Rivalry 11.5 Influence of COVID-19 and Russia-Ukraine War 11.5.1 Influence of COVID-19 11.5.2 Influence of Russia-Ukraine War 12 Upstream and Industry Chain 12.1 Raw Material of Pediatric Oncology Treatment and Key Suppliers 12.2 Manufacturing Costs Percentage of Pediatric Oncology Treatment 12.3 Pediatric Oncology Treatment Production Process 12.4 Industry Value Chain Analysis 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Research Process and Data Source 14.3 Disclaimer
It contains all the geographic trends, and market analysis for global market